Research programme: respiratory syncytial virus vaccines - BlueWillow Biologics

Drug Profile

Research programme: respiratory syncytial virus vaccines - BlueWillow Biologics

Alternative Names: Nanoemulsion adjuvanted intramuscular RSV vaccine - BlueWillow Biologics; Nanoemulsion adjuvanted intranasal RSV vaccine - BlueWillow Biologics

Latest Information Update: 09 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NanoBio Corporation
  • Developer BlueWillow Biologics
  • Class Respiratory syncytial virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Respiratory syncytial virus infections

Most Recent Events

  • 07 May 2018 NanoBio Corporation is now called BlueWillow Biologics
  • 27 Dec 2016 Preclinical development is ongoing for Respiratory-syncytial-virus-infections (Prevention) in USA (Intranasal) (NanoBio's pipeline, December 2016)
  • 19 Dec 2016 NanoBio has patent protection for nano-emulsion respiratory syncytial virus vaccines in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top